Lwin TM, Turner MA, Amirfakhri S, Nishino H, Hoffman RM, Bouvet M (2022) Fluorescence Molecular Targeting of Colon Cancer to Visualize the Invisible
identification of myelin oligodendrocyte glycoprotein 10 antibodies in optic neuritis subclasses) [5], advances in imaging (i.e
However, clinicians should recognize that any use of GLP-1 agonists in Crohn's disease patients remains off-label and requires careful consideration of the established evidence base for IBD management
When to seek help red flags: Contact your GP or trial clinician promptly if you experience persistent or worsening nausea and vomiting, are unable to keep fluids down for more than 24 hours, or notice significant unintentional weight loss or difficulty maintaining adequate nutrition
Replacement effects are summarized in the first paragraph followed by our data interpretation in the second paragraph: Regression and pattern analyses revealed sequential kinetics for all mutants with an apparent common intersection point at the x axis (Supplementary Fig
